Bio-Techne Corp (TECH)
TECH moved a median of -0.06% 30 minutes after news, and -0.17% by the close. How TECH actually reacts to news — the realized, point-in-time move the market made, measured across 363 labeled events over the last three years with zero look-ahead.
TECH’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.04% | 45% | 363 |
| 30-min | -0.06% | 44% | 363 |
| 60-min | -0.12% | 44% | 363 |
| to close | -0.17% | 42% | 362 |
| Middle 50% of TECH reactions | -1.14% to +0.42% |
|---|---|
| Median reaction (30-min) | -0.06% |
| Measured reactions | 363 |
Half of all Bio-Techne Corp news events land between -1.14% and +0.42% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How TECH reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 25 | -0.57% | 36% | -0.29% |
| Analyst downgrades | 55 | +0.17% | 58% | +0.20% |
| Coverage initiations | 20 | +0.28% | 65% | +0.59% |
| Rating reiterations | 54 | -0.05% | 46% | +0.50% |
| Price-target raises | 15 | -0.05% | 40% | +0.81% |
| Price-target cuts | 17 | +0.16% | 65% | +0.32% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. See how TECH ranks against every other measured name →
That’s how TECH usually reacts — get an email when it moves on news →Email me when TECH moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to TECH's baseline. Nothing else.
Recent TECH events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development | Press release | PR Newswire | +0.01% | -0.14% | |
| Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany | Press release | PR Newswire | +0.10% | +0.03% | |
| Form 8-K BIO-TECHNE Corp For: Sep 23 | SEC filing · Form 8-K | SEC EDGAR | -0.03% | +0.04% | |
| Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration | Press release | Canada Newswire | +0.04% | +0.08% | |
| Form 8-K BIO-TECHNE Corp For: Sep 14 | SEC filing · Form 8-K | SEC EDGAR | +0.06% | +0.08% | |
| Form DEFA14A BIO-TECHNE Corp | SEC filing · Form DEFA14A | SEC EDGAR | +0.06% | +0.08% | |
| Form DEFA14A BIO-TECHNE Corp | SEC filing · Form DEFA14A | SEC EDGAR | +0.01% | -0.25% | |
| Halper Sadeh LLC is Investigating Whether TECH, CBAN, AUUD are Obtaining Fair Deals for their Shareholders | Press release | GlobeNewswire | +0.05% | -0.07% | |
| Form DEFA14A BIO-TECHNE Corp | SEC filing · Form DEFA14A | SEC EDGAR | +0.01% | +0.14% | |
| Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals | Press release | PR Newswire | -0.06% | -0.25% | |
| Form DEFA14A BIO-TECHNE Corp | SEC filing · Form DEFA14A | SEC EDGAR | +0.04% | +0.07% | |
| Form 10-K BIO-TECHNE Corp For: Jun 30 | SEC filing · Form 10-K | SEC EDGAR | -0.06% | -0.03% | |
| TECH Stock Alert: Halper Sadeh LLC is Investigating Whether Bio-Techne Corporation is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | +0.00% | +0.11% | |
| Form DEFM14A BIO-TECHNE Corp | SEC filing · Form DEFM14A | SEC EDGAR | -0.04% | +0.00% | |
| Bio-Techne Corrects Dividend Announcement | Press release | PR Newswire | +0.03% | -0.06% | |
| Bio-Techne Declares Dividend | Press release | PR Newswire | -0.02% | +0.15% | |
| Bio-Techne Releases Fourth Quarter Fiscal 2026 Results | Press release | PR Newswire | -0.02% | +0.15% | |
| Form 8-K BIO-TECHNE Corp For: Aug 12 | SEC filing · Form 8-K | SEC EDGAR | -0.02% | +0.15% | |
| Form DEFA14A BIO-TECHNE Corp | SEC filing · Form DEFA14A | SEC EDGAR | +0.10% | +0.32% | |
| Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio | Press release | PR Newswire | -0.12% | +0.44% | |
| Halper Sadeh LLC is Investigating Whether ACA, TECH, IRDM, LCII are Obtaining Fair Deals for their Shareholders | Press release | GlobeNewswire | +0.01% | +0.13% | |
| Halper Sadeh LLC is Investigating Whether IRDM, TECH, SUNE, ACA are Obtaining Fair Deals for their Shareholders | Press release | GlobeNewswire | +0.07% | -0.02% | |
| Form 8-K BIO-TECHNE Corp For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | -0.15% | +0.21% | |
| Form 8-K BIO-TECHNE Corp For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | +0.10% | +0.76% | |
| Form DEFA14A BIO-TECHNE Corp | SEC filing · Form DEFA14A | SEC EDGAR | -0.15% | +0.21% | |
| Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets | Press release | PR Newswire | +0.10% | +0.76% | |
| TECH Stock Alert: Halper Sadeh LLC is Investigating Whether Bio-Techne Corporation is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | +0.10% | +0.76% | |
| Bio-Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization | Press release | PR Newswire | -0.22% | +2.45% | |
| Form SD BIO-TECHNE Corp | SEC filing · Form SD | SEC EDGAR | -0.34% | -0.28% | |
| Bio-Techne Declares Dividend | Press release | PR Newswire | -9.77% | -16.36% | |
| Bio-Techne Releases Third Quarter Fiscal 2026 Results | Press release | PR Newswire | -9.77% | -16.36% | |
| Form 10-Q BIO-TECHNE Corp For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.42% | +8.27% | |
| Form 8-K BIO-TECHNE Corp For: May 06 | SEC filing · Form 8-K | SEC EDGAR | -9.77% | -16.36% | |
| Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference | Press release | PR Newswire | +1.05% | +0.46% | |
| Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity | Press release | Canada Newswire | -1.51% | -1.29% | |
| Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results | Press release | PR Newswire | +1.00% | +1.09% | |
| Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite | Press release | PR Newswire | +0.67% | +0.00% | |
| Bio-Techne to Present at Upcoming Investor Conferences | Press release | PR Newswire | -0.74% | +5.34% | |
| Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical Laboratories | Press release | PR Newswire | -0.15% | -2.21% | |
| Bio-Techne Announces Changes to its Leadership Team | Press release | PR Newswire | -0.98% | -1.37% | |
| Form 8-K BIO-TECHNE Corp For: Feb 09 | SEC filing · Form 8-K | SEC EDGAR | -0.66% | -5.22% | |
| Bio-Techne Declares Dividend | Press release | PR Newswire | -3.28% | +2.97% | |
| Bio-Techne Releases Second Quarter Fiscal 2026 Results | Press release | PR Newswire | -3.28% | +2.97% | |
| Form 10-Q BIO-TECHNE Corp For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.42% | -3.20% | |
| Form 8-K BIO-TECHNE Corp For: Feb 04 | SEC filing · Form 8-K | SEC EDGAR | -3.28% | +2.97% | |
| Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative | Press release | PR Newswire | +0.15% | +2.71% | |
| Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers | Press release | PR Newswire | -0.75% | -3.56% | |
| Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results | Press release | PR Newswire | -1.50% | +3.03% | |
| Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference | Press release | PR Newswire | -0.09% | +0.29% | |
| Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology | Press release | PR Newswire | +0.50% | -0.17% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the TECH section they belong to.
Where else TECH is measured.
TECH earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| RadNet, Inc. (RDNT) | 364 | +0.09% | 53% |
| Aerpio Pharmaceuticals, Inc (ARPO) | 363 | 0.00% | 32% |
| Tenet Healthcare Corporation (THC) | 363 | +0.22% | 60% |
| Vanda Pharmaceuticals Inc. (VNDA) | 363 | -0.22% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Bio-Techne Corp's median reaction calculated?
Every labeled TECH news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 363 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 44% of TECH's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does TECH's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.